The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Social controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
Sundström, C., & Nilsson, K. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170504 · Cited by 2,407
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
COLLINS, S. J., GALLO, R. C., & GALLAGHER, R. E. (1977) · Nature · doi:10.1038/270347a0 · Cited by 2,094
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Verheij, M., Bose, R., Hua Lin, X., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., et al. (1996) · Nature · doi:10.1038/380075a0 · Cited by 1,767
Self-citationA class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Self-citationMichalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
Dunaief, J. L., Strober, B. E., Guha, S., Khavari, P. A., Ålin, K., Luban, J., Begemann, M., Crabtree, G. R., & Goff, S. P. (1994) · Cell · doi:10.1016/0092-8674(94)90405-7 · Cited by 624
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535
Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation
Wang, J., & Walsh, K. (1996) · Science · doi:10.1126/science.273.5273.359 · Cited by 489
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Self-citationHL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis
MARTIN, S. J., BRADLEY, J. G., & COTTER, T. G. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb08110.x · Cited by 381
Medina, V., Edmonds, B., Young, G. P., James, R., Appleton, S., & Zalewski, P. D. (1997) · PubMed · Cited by 377
Ogryzko, V. V., Hirai, T. H., Russanova, V. R., Barbie, D. A., & Howard, B. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5210 · Cited by 268 · cited 1×
“SAHA, like the four-carbon short-chain fatty acid butyrate (Archer et al., 1998), functions as an inhibitor of histone deacetylase (HDI) (Richon et al., 1998), an enzyme implicated in regulation of histone acetylation and genes implicated in cellular maturation (Ogryzko et al., 1996).”
BackgroundFrequent mutations in the p53 gene in human myeloid leukemia cell lines
Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y., & Hirai, H. (1992) · Blood · doi:10.1182/blood.v79.9.2378.2378 · Cited by 213
Ohta, H., Sweeney, E. A., Masamune, A., Yatomi, Y., Hakomori, S., & Igarashi, Y. (1995) · PubMed · Cited by 213
Gervais, J. L. M., Seth, P., & Zhang, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19207 · Cited by 212
McBain, J. A., Eastman, A., Nobel, C. S., & Mueller, G. C. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00904-5 · Cited by 165
Bcl2 inhibits apoptosis associated with terminal differentiation of HL- 60 myeloid leukemia cells
Naumovski, L., & Cleary, M. L. (1994) · Blood · doi:10.1182/blood.v83.8.2261.2261 · Cited by 134
Andreeff, M., Stone, R. M., Michaeli, J., Cw, Y., Tong, W., Sogoloff, H., Ervin, T. J., Kufe, D. W., Rifkind, R. A., & Marks, P. (1992) · Blood · doi:10.1182/blood.v80.10.2604.2604 · Cited by 124
Vaziri, C., Stice, L. L., & Faller, D. V. (1998) · PubMed · Cited by 109
Neuronal apoptosis induced by histone deacetylase inhibitors
Salminen, A., Tapiola, T., Korhonen, P., & Suuronen, T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00210-1 · Cited by 108
Kharbanda, S. M., Saleem, A., Emoto, Y., Stone, R. M., Rapp, U. R., & Kufe, D. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42193-4 · Cited by 102
Dangond, F., & Gullans, S. R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8891 · Cited by 96
Wang, S., Vrana, J. A., Bartimole, T. M., et al. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1000 · Cited by 79
Self-citationTang, H.-Y. J., Zhao, K., Pizzolato, J. F., Fonarev, M., Langer, J., & Manfredi, J. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29156 · Cited by 70
Vrana, J. A., Saunders, A. M., Chellappan, S., & Grant, S. (1998) · Differentiation · doi:10.1046/j.1432-0436.1998.6310033.x · Cited by 62
Self-citationWang, Z., Su, Z.-Z., Fisher, P. B., Wang, S., VanTuyle, G., & Grant, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4191 · Cited by 53
Self-citationSelvakumaran, M., Reed, J., Liebermann, D. A., & Hoffman‐Liebermann, B. (1994) · Blood · doi:10.1182/blood.v84.4.1036.1036 · Cited by 40
Ehinger, M., Bergh, G., Olofsson, T., Baldetorp, B., Olsson, I., & Gullberg, U. (1996) · Blood · doi:10.1182/blood.v87.3.1064.bloodjournal8731064 · Cited by 35
Self-citationMarengo, S. R., Sikes, R. A., Anezinis, P., Chang, S., & Chung, L. W. K. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199707)19:3<204::aid-mc8>3.0.co;2-d · Cited by 27
Cited by
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Self-citationHistone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Histone Deacetylase Inhibitors as Anticancer Drugs
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071414 · Cited by 1,206
Metadata
- Authors
- Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., & Grant, S.
- Venue
- Oncogene
- Published
- 1999-11-25
- Volume
- 18
- Issue
- 50
- Pages
- 7016-7025
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2034420402
- Cited by
- 284
- References
- 32
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.